113 related articles for article (PubMed ID: 32428139)
1. Hematological changes in Covid-19 infections.
Duarte FB; Lemes RPG; Duarte IA; Duarte BA; Duarte JVA
Rev Assoc Med Bras (1992); 2020 May; 66(2):99. PubMed ID: 32428139
[No Abstract] [Full Text] [Related]
2. Pediatric patients with benign hematological diseases during the COVID-19 pandemic.
Bayhan T; Şahin S; Çulha V; Özbek N; Yaralı N
Pediatr Blood Cancer; 2020 Sep; 67(9):e28595. PubMed ID: 32667695
[No Abstract] [Full Text] [Related]
3. Cautious interpretation of antiphospholipid antibodies in COVID-19.
Mehta S; Bhandari S; Mehta S
Clin Chim Acta; 2020 Oct; 509():166. PubMed ID: 32553721
[No Abstract] [Full Text] [Related]
4. Covid-19 antibody tests: a briefing.
Baraniuk C
BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
[No Abstract] [Full Text] [Related]
5. High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.
Boukli N; Le Mene M; Schnuriger A; Cuervo NS; Laroche C; Morand-Joubert L; Gozlan J
J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848041
[No Abstract] [Full Text] [Related]
6. Labs scramble to produce new coronavirus diagnostics.
Cohen J; Kupferschmidt K
Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
[No Abstract] [Full Text] [Related]
7. Interleukin-6 as a potential biomarker of COVID-19 progression.
Ulhaq ZS; Soraya GV
Med Mal Infect; 2020 Jun; 50(4):382-383. PubMed ID: 32259560
[No Abstract] [Full Text] [Related]
8. Researchers Home in on COVID-19 Severity Biomarkers.
Abbasi J
JAMA; 2020 Jul; 324(2):128. PubMed ID: 32662846
[No Abstract] [Full Text] [Related]
9. Emerging key laboratory tests for patients with COVID-19.
Kavsak PA; de Wit K; Worster A
Clin Biochem; 2020 Jul; 81():13-14. PubMed ID: 32360478
[No Abstract] [Full Text] [Related]
10. Insights into pediatric multi-system inflammatory syndrome and COVID-19.
Bar-Or D; Rael LT; Brody EN
Clin Chim Acta; 2020 Nov; 510():121-122. PubMed ID: 32673668
[No Abstract] [Full Text] [Related]
11. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019.
Perlini S; Ciprandi G; Castagnoli R; Licari A; Marseglia GL
Allergy Asthma Proc; 2020 Nov; 41(6):e80-e82. PubMed ID: 33109314
[No Abstract] [Full Text] [Related]
12. Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys® Anti-SARS-CoV-2 assay.
Tang NY; Yeo KJ; van Wijk XMR
Clin Chim Acta; 2020 Oct; 509():293-294. PubMed ID: 32598879
[No Abstract] [Full Text] [Related]
13. Two consecutive myocardial tissue insults for inpatients with COVID-19.
Su M; Peng J; Wu M; Deng W; Yang Y; Peng YG
Crit Care; 2020 May; 24(1):259. PubMed ID: 32456648
[No Abstract] [Full Text] [Related]
14. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19.
Solodky ML; Galvez C; Russias B; Detourbet P; N'Guyen-Bonin V; Herr AL; Zrounba P; Blay JY
Ann Oncol; 2020 Aug; 31(8):1087-1088. PubMed ID: 32360743
[No Abstract] [Full Text] [Related]
15. COVID-19 and fortuitous discovery of chronic lymphocytic leukemia: biological findings and therapeutic challenges.
Charra B; Ellouadghiri A; Magramane A; Kebbou T; Damaan K; Maghfour A; Seddiki K; Ezzouine H
Pan Afr Med J; 2020; 36():286. PubMed ID: 33117480
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-related atypical thyroiditis.
Muller I; Cannavaro D; Dazzi D; Covelli D; Mantovani G; Muscatello A; Ferrante E; Orsi E; Resi V; Longari V; Cuzzocrea M; Bandera A; Lazzaroni E; Dolci A; Ceriotti F; Re TE; Gori A; Arosio M; Salvi M
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):739-741. PubMed ID: 32738929
[No Abstract] [Full Text] [Related]
17. An Uncomplicated Delivery in a Patient with Covid-19 in the United States.
Iqbal SN; Overcash R; Mokhtari N; Saeed H; Gold S; Auguste T; Mirza MU; Ruiz ME; Chahine JJ; Waga M; Wortmann G
N Engl J Med; 2020 Apr; 382(16):e34. PubMed ID: 32237670
[No Abstract] [Full Text] [Related]
18. SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone.
Visani G; Chiarucci M; Guiducci B; Capalbo M; Isidori A
Ann Hematol; 2020 Jul; 99(7):1677-1678. PubMed ID: 32535706
[No Abstract] [Full Text] [Related]
19. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies.
Goetz L; Yang J; Greene W; Zhu Y
J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181
[No Abstract] [Full Text] [Related]
20. The Promise and Peril of Antibody Testing for COVID-19.
Abbasi J
JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
